GATA3 and hepatocellular carcinoma: Also in HCC, VIRMA also mediated the m6A modification of GATA3 pre-mRNA, inhibited its binding to the RNA-binding protein HuR, thus reduced the stability of GATA3 pre-mRNA, and ultimately led to downregulation of GATA3 expression.